Chinese tech stocks fall sharply on rising regulatory concerns - FT中文网
登录×
电子邮件/用户名
密码
记住我
请输入邮箱和密码进行绑定操作:
请输入手机号码,通过短信验证(目前仅支持中国大陆地区的手机号):
请您阅读我们的用户注册协议隐私权保护政策,点击下方按钮即视为您接受。
中国经济

Chinese tech stocks fall sharply on rising regulatory concerns

Alibaba, Tencent and Baidu shares drop on fears of US delistings and control over data
00:00

{"text":[[{"start":12.74,"text":"Chinese technology stocks dropped sharply on growing concerns of possible delistings from US exchanges and reported plans by Beijing to take control of companies’ user data. "}],[{"start":24.79,"text":"The Hong Kong-listed shares of Alibaba, the Chinese ecommerce group, were down 4.2 per cent by midday on Thursday, while those of internet business Tencent dropped 2.3 per cent. "},{"start":37.707,"text":"Shares in Baidu, the search engine group that debuted in the city this week, tumbled almost 9 per cent. "}],[{"start":45.69,"text":"Hong Kong’s Hang Seng Tech index, which tracks shares in big Chinese tech groups, fell as much as 5 per cent. "}],[{"start":54.55,"text":"The losses came after the US Securities and Exchange Commission said on Wednesday that it was taking initial steps to force foreign companies listed in New York to provide access to financial audits or risk being forcibly delisted after three years of non-compliance. "},{"start":70.704,"text":"Beijing has long denied US regulators access to Chinese companies’ books. "}],[{"start":76.75,"text":"Analysts said sentiment was also hit on Thursday by a Bloomberg News report that China’s government had proposed creating a joint venture to oversee all user data harvested by the country’s tech companies. "}],[{"start":90.41,"text":"If implemented, the plan would mark a substantial escalation of a regulatory crackdown on China’s tech sector, which state media and top officials have criticised for amassing too much power and influence. "}],[{"start":104.35,"text":"“Without a shadow of a doubt you’re going to see a correction” of Chinese tech shares, said Andy Maynard, a Hong Kong-based trader at China Renaissance, an investment bank. "},{"start":114.967,"text":"“I literally don’t have a buy order [for Alibaba]. ”"}],[{"start":119.49,"text":"Maynard added that the latest round of bad news for Chinese tech groups had piled additional pressure on share prices already hit by a global shift in investor attention from high-growth companies to cheaper, unloved stocks that are expected to benefit as the global economy recovers from Covid-19. "}],[{"start":138.59,"text":"Louis Tse, managing director at brokerage Wealthy Securities in Hong Kong, said the SEC’s move would put pressure on China to respond to demands for access to audit reports at a time of growing acrimony between Washington and Beijing. "}],[{"start":154.69,"text":"“China doesn’t want [companies] to disclose anything for national security reasons,” he said. "},{"start":161.482,"text":"“That is a very big question that has to be answered by the Chinese side. ”"}],[{"start":166.82999999999998,"text":"The threat of delisting has not stopped Chinese tech groups from selling shares on Wall Street, with these companies raising about $1.3bn from New York listings this year. "},{"start":178.05899999999997,"text":"Their shares rose 22 per cent on average on their first trading day, according to data from Dealogic. "}],[{"start":185.90999999999997,"text":"“A lot of parties have a huge interest in these Chinese IPOs,” Tse added, pointing to the fee revenues enjoyed by the Wall Street investment banks. "},{"start":195.47699999999998,"text":"“How can they give that up? ”"}],[{"start":198.19999999999996,"text":"The broader Hang Seng index was little changed on Thursday. "}],[{"start":202.01999999999995,"text":""}]],"url":"https://creatives.ftacademy.cn/album/001091922-1616654933.mp3"}

版权声明:本文版权归FT中文网所有,未经允许任何单位或个人不得转载,复制或以任何其他方式使用本文全部或部分,侵权必究。

反弹的通胀与不耐烦的特朗普:凯文•沃什面临双重压力

美国参议院本周有望批准这位56岁的金融家接替杰伊•鲍威尔出任美联储主席。

伊朗战争推高燃气价格,印度工人纷纷逃离城市生活

伊朗战争推高了烹饪燃料价格,迫使印度许多务工人员返乡回村。

能源、军火与粮食:特朗普对伊战争日益沉重的代价

这场冲突正波及整个美国经济,造成了数千亿美元的产出损失。

肺纤维化生物科技公司Avalyn Pharma申请首次公开募股(IPO)

一家生物技术公司正开发可吸入剂型的已获批肺纤维化口服药,计划赴公开市场融资以支持其后期研发。
2天前

凯勒拉治疗学公司在生物技术领域创纪录的IPO中融资6.25亿美元

最新的生物科技公司首次公开募股创下历史新高。
3天前

法国将迎来最拥挤的大选角逐场:谁将取代马克龙?

左翼和中间阵营的分裂,助长了极右翼问鼎爱丽舍宫的希望。
设置字号×
最小
较小
默认
较大
最大
分享×